World's Best Scientists 2026 revealed!
David W. Dodick

David W. Dodick

D-Index & Metrics

Medicine

D-Index
118
Citations
64528
World Ranking
3998
National Ranking
2185

David W. Dodick publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David W. Dodick sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 759 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David W. Dodick D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David W. Dodick sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 118 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David W. Dodick is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on the fields of medicine, with particular emphasis on psychiatry and mental health, pathology and forensic medicine, neurology, physiology, and epidemiology.

The scientist's work covers various topics including:

  • Migraine and Headache Studies
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Psychosomatic Disorders and Their Treatments
  • Traumatic Brain Injury Research
  • Olfactory and Sensory Function Studies
  • Neurological Disorders and Treatments

David W. Dodick has contributed to multiple scientific publications, some of the recent notable papers include:

  • "Migraine," 2022, Nature Reviews Disease Primers
  • "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome," 2021, Neurology
  • "Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study," 2020, The Journal of Headache and Pain
  • "Migraine: integrated approaches to clinical management and emerging treatments," 2021, The Lancet
  • "Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial," 2020, The Lancet Neurology

Their research has been published frequently in the following venues:

  • Neurology
  • Headache The Journal of Head and Face Pain
  • Cephalalgia
  • The Journal of Headache and Pain
  • Alzheimer's & Dementia

David W. Dodick has collaborated extensively with other researchers, including frequent coauthors:

  • Richard B. Lipton
  • Todd J. Schwedt
  • Peter J. Goadsby
  • Frank Porreca
  • Edita Navratilova

In addition to articles, Dodick has contributed to the book titled Oxford Textbook of Headache Syndromes, published by Oxford University Press in 2020.

Best Publications

  • The International Classification of Headache Disorders, 3rd edition (beta version)

    Jes Olesen;André Bes;Robert Kunkel;James W. Lance

  • OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

    HC Diener;DW Dodick;SK Aurora;CC Turkel

  • A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

    Brian G. Weinshenker;Peter C. O'Brien;Tanya M. Petterson;John H. Noseworthy

  • New Appendix Criteria Open for a Broader Concept of Chronic Migraine

    J. Olesen;M -G Bousser;H -C Diener;D. Dodick

  • OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

    David W. Dodick;Catherine C. Turkel;Ronald E. Degryse;Sheena K. Aurora

  • Narrative review: reversible cerebral vasoconstriction syndromes.

    Leonard H. Calabrese;David W. Dodick;Todd J. Schwedt;Aneesh B. Singhal

  • Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

    S.D. Silberstein;S. Holland;F. Freitag;D.W. Dodick

  • Fremanezumab for the Preventive Treatment of Chronic Migraine

    Stephen D. Silberstein;David W. Dodick;Marcelo E. Bigal;Paul P. Yeung

  • Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

    Tony W Ho;Michel D Ferrari;David W Dodick;Vince Galet

  • A self-administered screener for migraine in primary care: The ID Migraine™ validation study

    Richard B. Lipton;D. Dodick;R. Sadovsky;K. Kolodner

  • Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

    Stephen D. Silberstein;Richard B. Lipton;David W. Dodick;Frederick G. Freitag

  • ARISE: A Phase 3 randomized trial of erenumab for episodic migraine:

    David W Dodick;Messoud Ashina;Jan Lewis Brandes;David Kudrow

  • Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

    Virginia L. Stauffer;David W. Dodick;Qi Zhang;Jeffrey N. Carter

  • Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

    Richard B Lipton;David W Dodick;Stephen D Silberstein;Joel R Saper

  • Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.

    Joel R Saper;David W Dodick;Stephen D Silberstein;Sally McCarville

  • Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.

    David W. Dodick;Stephen D. Silberstein;Marcelo E. Bigal;Paul P. Yeung

  • The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.

    Stephen D. Silberstein;J. Olesen;M. G. Bousser;H. C. Diener

  • Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

    David W Dodick;Peter J Goadsby;Peter J Goadsby;Stephen D Silberstein;Richard B Lipton

  • Adherence to oral migraine-preventive medications among patients with chronic migraine:

    Zsolt Hepp;David W Dodick;Sepideh F Varon;Patrick Gillard

  • Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

    David W Dodick;Peter J Goadsby;Peter J Goadsby;Egilius L H Spierings;Egilius L H Spierings;Egilius L H Spierings;Joel C Scherer

Frequent Co-Authors

Stephen D. Silberstein
Stephen D. Silberstein Thomas Jefferson University
Richard B. Lipton
Richard B. Lipton Albert Einstein College of Medicine
Peter J. Goadsby
Peter J. Goadsby King's College London
Frank Porreca
Frank Porreca University of Arizona
Hans-Christoph Diener
Hans-Christoph Diener University of Duisburg-Essen
Messoud Ashina
Messoud Ashina University of Copenhagen
Michel D. Ferrari
Michel D. Ferrari Leiden University Medical Center
Stewart J. Tepper
Stewart J. Tepper Dartmouth College
Shuu-Jiun Wang
Shuu-Jiun Wang National Yang Ming Chiao Tung University
Marcelo E. Bigal
Marcelo E. Bigal Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens a wealth of opportunities for those interested in healthcare. Many students explore alternative online degrees and fast-track pathways to enter or advance in the field more quickly. For instance, some healthcare professionals seek the shortest online dnp program options to achieve a Doctor of Nursing Practice degree efficiently.

Flexibility is another major benefit, with some online dnp programs without clinicals reducing hands-on requirements for experienced candidates. Aspiring practical nurses may also consider accelerated lpn programs designed to help students enter the workforce quickly.

Specialized fields are expanding as well. Those interested in mental health might opt for psychiatric np programs, providing advanced credentials in psychiatric nursing via online study. Exploring these diverse educational pathways can help you tailor your career in medicine to your goals and timeline.

Best Scientists Citing David W. Dodick

Trending Scientists

Recently Published Articles